InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Grissinger Michael. Director active across 1 company, notably Aprea Therapeutics, Inc.. In total, 5 reports have been published. History available since 28 July 2022. The latest transaction was filed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Grissinger Michael is a declarant and is listed as a director of Aprea Therapeutics, Inc. on XNAS. He has 5 filings in total, and the sampled recent filings cover the period from 2022-08-01 to 2026-06-17, with buy and sell amounts of 0, and a modal transaction nature indicated as Attribution.